FDA Approves Invega Hafyera (paliperidone palmitate) for Twice-Yearly Treatment for Adults with Schizophrenia TITUSVILLE, N.J., Sept. 1, 2021 – The Janssen Pharmaceutical Companies of Johnson
Read more
Home »
FDA Approves Nexviazyme
FDA Approves Nexviazyme (avalglucosidase alfa-ngpt) for Late-Onset Pompe Disease PARIS – August 6, 2021 – The U.S. Food and Drug Administration (FDA) has approved Nexviazyme
Read more
A Family Wellness Check: California Invests in Treating Parents and Children Together
When a parent takes an infant to the Children’s Health Center in San Francisco for a routine checkup, a pediatrician will check the baby’s vitals
Read more
U.S. Food and Drug Administration Approves New Formulation of Epclusa, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C
FOSTER CITY, Calif.–(BUSINESS WIRE)–Jun. 10, 2021– Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved an expansion
Read more
FDA Approves Tembexa
FDA Approves Tembexa (brincidofovir) for the Treatment of Smallpox DURHAM, N.C., June 04, 2021 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating
Read more
Has agregado a tus hijos a tu plan de salud. ¿Y tu mamá?
SACRAMENTO – Cuando la madre de Laura Chávez, de 74 años, tuvo que operarse de la vista el mes pasado, Chávez pagó en efectivo por
Read more
Farxiga Approved in the US for the Treatment of Chronic Kidney Disease in Patients at Risk of Progression With and Without Type-2 Diabetes
30 April 2021 Approval is the most significant advancement in the treatment of chronic kidney disease in more than 20 years In DAPA-CKD Phase III
Read more
FDA Approves Kloxxado
FDA Approves Kloxxado (naloxone hydrochloride) Nasal Spray for Emergency Treatment of Opioid Overdose LONDON, April 30, 2021 /PRNewswire/ — Hikma Pharmaceuticals PLC (Hikma), the multinational
Read more
Jazz Pharmaceuticals Announces FDA Approval of Additional Indication for Vyxeos (daunorubicin and cytarabine) for the Treatment of Secondary Acute Myeloid Leukemia in Pediatric Patients
DUBLIN, March 30, 2021 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved a revised label for Vyxeos® (daunorubicin and cytarabine) to
Read more
KHN’s ‘What the Health?’: All About Budget Reconciliation
Can’t see the audio player? Click here to listen on SoundCloud. President Joe Biden has said he still wants a bipartisan bill to provide the next
Read more